ProShare Advisors’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-34,261
| Closed | -$3.34M | – | 1904 |
|
|
2015
Q1 | $3.34M | Buy |
34,261
+7,668
| +29% | +$748K | 0.04% | 407 |
|
|
2014
Q4 | $2.47M | Buy |
26,593
+1,005
| +4% | +$93.3K | 0.03% | 510 |
|
|
2014
Q3 | $1.76M | Sell |
25,588
-4,884
| -16% | -$336K | 0.02% | 792 |
|
|
2014
Q2 | $3.19M | Sell |
30,472
-12,497
| -29% | -$1.31M | 0.04% | 471 |
|
|
2014
Q1 | $3.57M | Buy |
42,969
+28,058
| +188% | +$2.33M | 0.04% | 404 |
|
|
2013
Q4 | $965K | Sell |
14,911
-5,532
| -27% | -$358K | 0.01% | 988 |
|
|
2013
Q3 | $1.29M | Buy |
20,443
+7,919
| +63% | +$501K | 0.03% | 676 |
|
|
2013
Q2 | $526K | Buy |
+12,524
| New | +$526K | 0.01% | 1301 |
|